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Web Appendix A Conditional Distributions and Poste-
rior Computation
In our AFT model for group correlation structure, most of the conditional distributions are
available explicitly, hence we can employ Gibbs sampling (Gelfand et al., 1990) technique to
explore the posterior distribution. In particular, the complete conditional distributions of β,
σ2, and bP are given by:
β|w, λ, τ, σ2 ∼N(A−1(XTw +D−1bP ), σ2A−1)

































where, A = (XTX +D−1), D = τ 2diag
(




, and bP = (bP1, . . . , bPp)
′.
Due to the nature of the prior on λ and τ , straightforward Gibbs sampling approach may






2003), has been discussed in the online supplement of Polson et al. (2014). It follows that,

















and introducing a latent parameter ujk, the conditional posterior
distribution looks like,













Then the following scheme will be used to sample the posterior distribution of λ:
1. Sample ujk|φjk ∼ U(0, 11+φjk ).











Updating τ can be carried out in the similar fashion. We introduce a latent variable v
and let ξ = 1
τ2
to yield desired posterior samples:
1. Sample v|ξ ∼ U(0, 1
1+ξ
).












3. Plug back in τ = 1√
ξ
.






cated at log t∗ik.
The Markov Chain Monte Carlo (MCMC) chain for simultaneous correlation among
groups and proteins (Section 2.3 in the main article) can be constructed extending the
strategies detailed above. We implement both types of correlation models along with original
horseshoe for a single log normal AFT model in R package hsaft and make them available
at https://github.com/arnabkrmaity/hsaft/tree/master/hsaft.
Web Appendix B Prediction of Survival Curve
When the interest is to predict the survival time of a new subject having covariate vector












βp(w, β, λ, τ, σ2|t∗, δ)dwdβdλdτdσ2
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β(m)|λ(m), τ (m), (σ2)(m)
where M is the MCMC sample size.
In a very similar manner one obtains the estimated survival probability at time t0,




















Web Appendix C Impact of the Variance of the mean
hyperparameter
To demonstrate that the kidney tumor groups for each protein are correlated, we compute the
posterior correlation of β given in (2) using MCMC samples from the rst chain. We consider
4 proteins X1433EPSILON, X4EBP1, FOXO3A_pS318S321, DIRAS3, among which the
last two proteins were declared signicant by our analysis. Web Table S1 exhibits the
computed posterior correlations and one can note that the estimates are indeed high which
supports the argument in favor of correlated (or integrated) data analysis. Additionally, we
provide the posterior summaries such as trace plots of correlation between tumor groups for
the proteins X1433EPSILON, X4EBP1, FOXO3A_pS318S321, and DIRAS3 which indicates













Figure S1: Observed Kaplan-Meier plots for three tumor groups  KICH, KIRC, and KIRP.
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Table S1: Posterior correlation of tumor groups for proteins.
Protein KICH and KIRC KICH and KIRP KIRC and KIRP
X1433EPSILON 0.832 0.860 0.842
X4EBP1 0.886 0.892 0.885
FOXO3A_pS318S321 0.727 0.729 0.739
DIRAS3 0.701 0.708 0.725
In the following, we examine the variable selection behavior under the inuence of the
choice of the variance σ2P in (2) in the main article. To do this, we consider group-corr
method in the setting of Example 1 discussed before. We consider several values of the
hyperparameter σ2P and compute the area under the ROC curve (AUC). Table S2 reports
the results. From these results one can conclude that the variable selection performance is
insensitive to the choice of the hyperparameter σ2P .














Web Appendix D Consistency
In this section, we investigate the frequentist asymptotic behavior of parameter estimates
in an AFT log-normal model with a horseshoe prior on the regression coecients. Bradic
et al. (2011) have shown consistency of nonconcave penalized methods for non-polynomial
(NP) dimensional data with censoring in the framework of frequentist Cox proportional
hazards model. For high-dimensional linear regression models, posterior consistency for the
horseshoe prior and its variants have been shown by Armagan et al. (2013). In the context of
nonparametric AFT models, Wu and Ghosal (2008) established posterior consistency of the
regression function. A combination of these two results provides a consistency result for the
regression parameters in the present situation, which is summarized in the following corollary.
To be specic, we consider the AFT model prior formulation in (1) for a single tumor group
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with bPj = 0, and prove that the posterior distribution concentrates in neighborhoods of the
true parameter under certain conditions. The result for any bPj is beyond the scope of this
paper and is due for future research.
Let Π(β) denote the prior on β and qn be the number of nonzero elements in β
0 where
β0 is the true value of β. We make use of the following assumptions,
1. p = o(n)
2. Let Λnmin and Λnmax be the smallest and the largest singular values of X, respec-









4. qn = o(n/ log n)
Corollary 1. Under conditions (1), . . . , (4) and for the horseshoe prior Π(β), the posterior
of β is strongly consistent, that is, for any ε > 0, Π(β : ||β − β0|| > ε|t)








for all 0 < ∆ < ε2Λ2min/(48Λ
2
max) and 0 < d < ε
2Λ2min/(32σ
2) − 3∆Λ2max/(2σ2) and some
ρ > 0.
Proof. Under the log normal AFT model, for a given ε and for a continuous prior Π(β) on
β, Theorem 7.1 of Wu and Ghosal (2008) implies that, as n→∞,
Π
(
β : ||β − β0|| > ε|t
)
Prβ0 a.s.→ 0.
In addition, when Π(β) is the horseshoe prior given in (1) with bPj = 0, then the prior mass
condition is veried by Theorem 1 of Armagan et al. (2013), which ensures that for any
ε > 0, Π(β : ||β − β0|| > ε|t)
Prβ0 a.s.→ 0 as n→∞, if
Π
(




for all 0 < ∆ < ε2Λ2min/(48Λ
2
max) and 0 < d < ε
2Λ2min/(32σ
2) − 3∆Λ2max/(2σ2) and some
ρ > 0. This completes the proof.
Web Appendix E Kidney Tumors
We t the Cox proportional hazard model and the log normal AFT model with randomly
selecting 10 covariates on the full dataset. We repeat this procedure 10 times and provide
the average AIC and BIC values in Table S3. We notice that goodness of t criteria such
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Table S3: AIC and BIC for Cox proportional hazard model and log normal AFT model for




as AIC and BIC are smaller for the log normal AFT model than those of of the Cox model.
This implies that the AFT model provides a better t at least on the subsets of the data.
Cross validation is a widely known method to test the model prediction performance. In
Bayesian statistics a similar technique was developed by Gelfand et al. (1990) based on the
conditional predictive ordinate (CPO). For the i-th observation yi = log ti, this is dened
by CPOi = f(yi|y−i) =
∫
f(yi|θ)π(θ|y−i)dθ, where y−i = y \ {yi}. Then the log pseudo
marginal likelihood (LPML) is constructed based on CPO as LPML = log
∏n
i=1 CPOi. By
construction, a model with higher LPML is preferred. In a time to data analysis setting
LPML has been routinely used, for example, see Ibrahim et al. (2002, 2005). When compared,
the LPML for our proposed group-corr method is higher than when the regressions are tted
with in each kidney cancer group (Table S4). This implies that the proposed method provides
a better t to the data with respect to the cross validation technique such as LPML.




Web Appendix F Tumors in Female Body
There exist at least 4 types of tumors  Breast invasive carcinoma (BRCA), Ovarian serous
cystadenocarcinoma (OV), Uterine Corpus Endometrial Carcinoma (UCEC), and Uterine
Carcinosarcoma (UCS), which are related to female body only. So the interest is to jointly
analyze the protein data for these tumors and to nd out the common proteins associated
with these tumors. Table S5 provides the estimated gures of new cancer cases and deaths
caused by these tumors in 2017 in the United States. Based on available TCPA data, in
Figure S4, we plot the observed Kaplan-Meier plots of these tumors. The BRCA data has
871 samples, the OV data has 430 samples and the two Uterine cancers are consist of 436
and 48 samples respectively. All four groups have 189 proteins as before.
We apply our developed methodologies in this data analysis to recover the major proteins
causing the cancers in female body. After running 4 MCMC chains the mean IBS produced
by group-corr method and all-corr method coincides at 0.170 while the same due to the local
method is 0.430 indicating the better predictive ability of the correlation structures. For
simplicity, again, we carry out the following analyses for group-corr method only because
both correlation structures have same IBS.
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Table S5: Estimated number of new Cancer Cases and Deaths in US, 2017 (American Cancer
Society 2017 report).
Tumor Cases Deaths
Breast invasive carcinoma 252,710 40,610
Ovarian serous cystadenocarcinoma 22,440 14,080
Uterine Corpus 61,380 10,920
In Figure S5, we depict the posterior estimates of the protein eects for local and group-
corr methods respectively. Next we identify top 14 signicant proteins which cause the
cancer in a female body using the method described in Section 3.1 in the main article. We
run 4 MCMC chains and the selected proteins for all 4 chains are listed in Table S6. Note
that, some of the proteins (e.g. FOXO3A_pS318S321, DIRAS3, SF2) are also signicant
related to kidney cancers. Nevertheless, Taylor et al. (2015) provided a detailed review
how FOXO3A has being targeted for breast cancer therapeutics. Moreover, Levanon et al.
(2014) suggested that the same FOXO3A should be targeted for ovary cancer therapeutics.
Similar conclusions have been drawn by Myatt et al. (2010) for uterine cancers. Among other
selected proteins the possible eect of RAD51 has been discussed in Lose et al. (2006), in Hu
and Sun (2015), and in Thacker (2005) for breast cancer, for ovary cancer, and for uterine
cancers respectively. The association of other proteins for development and progression of
female cancers are also well studied in the literature.
Table S6: Selected top 14 proteins for female cancers for 4 MCMC chains.
Chain 1 Chain 2 Chain 3 Chain 4
DIRAS3 DIRAS3 DIRAS3 DIRAS3
FOXO3A_pS318S321 SF2 RAD51 FOXO3A_pS318S321
PI3KP85 SHC_pY317 DIRAS3 SF2
BAK BAK PI3KP85 SHC_pY317
RAD51 FOXO3A_pS318S321 FOXO3A_pS318S321 MTOR
SF2 PI3KP85 SHC_pY317 BAK
MTOR MTOR MTOR MSH2
PCADHERIN RAD51 BAK BCLXL
DIRAS3 PRDX1 PCADHERIN PEA15
RAPTOR PAI1 RAPTOR RAD51
SHC_pY317 CYCLINE2 BAX DIRAS3
MSH2 DIRAS3 SF2 KU80
CD31 RBM15 PAI1 SHC_pY317
BCLXL SF2 BCLXL PI3KP85
EGFR_pY1068 BCLXL KU80 SMAD4
To conrm that the selected proteins are indeed important for the survival of the subjects
we carry out the following analysis. First, after tting a log normal AFT model using these
protein expressions the IBS is computed which is 0.187 which is close to the IBS obtained
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by group-corr method. We also randomly select 14 proteins and run a log normal AFT
model using these proteins. After repeating this procedure the resulting mean IBS of these
models is 0.669 which is higher than 0.187 and higher than the original IBS 0.170 obtained
by group-corr method.
Web Appendix G Correlation Between Coecients of Two
Groups
In the following we derive the correlation between two tumor groups k and k′, k 6= k′, given
the prior specication (1).




2σ2 + σ2P .
Similarly, Var(βjk′) = λ
2
jk′τ
2σ2 + σ2P .
Cov(βjk, βjk′) =E{Cov(βjk, βjk′ |bPj)}+ Cov{E(βjk|bPj), E(βjk′ |bPj)}
=0 + Cov(bPj , bPj)
=Var(bPj)
=σ2P .
This follows that, Corr(βjk, βjk′) = σ
2
P/{(λ2jkτ 2σ2 + σ2P )1/2(λ2jk′τ 2σ2 + σ2P )1/2}.
Web Appendix H Correlation Between Coecients of Two
Proteins
While borrowing strength among groups can be achieved using the prior structure as dis-
cussed in Section 2.2, one can argue for similar assumption of correlations among proteins
that is the proteins are correlated for each individual. This can be accomplished by sim-
ple addition of a mean parameter in prior (1), βjk|λjk, τ, σ2∼ N(bPj + bGk, λ2jkτ 2σ2), and
bGk∼ N(0, σ2G).
Here we derive the correlation induced by the prior specication in Section 2.3. We note
that, Cov(βjk, βj′k) = σ
2
G and Var(βjk) = λ
2
jkτ
2σ2 + σ2P + σ
2
G. This follows that, Corr(βjk, βj′k) =
σ2G/{(λ2jkτ 2σ2 + σ2P + σ2G)1/2(λ2j′kτ 2σ2 + σ2P )1/2 + σ2G}.
Web Appendix I Additional Simulations
In this section we consider additional simulation studies by keeping the same settings as in
Section for except set the eect size as 0.2 or -0.2 randomly. The area under the ROC curve
(AUC) results are given in Table S7, when we assume the independence among the groups.
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Table S7: Area under the ROC curves when groups are independent
Censoring Rate 35% 48% 76%
local 0.659 0.646 0.562
group-corr 0.690 0.668 0.577
all-corr 0.688 0.662 0.565
lasso 0.419 0.412 0.449
Table S8: Area under the ROC curves when groups are correlated.
Censoring Rate 35% 56% 76%
local 0.645 0.641 0.488
group-corr 0.699 0.680 0.586
all-corr 0.686 0.677 0.574
lasso 0.487 0.498 0.512
Furthermore, when we consider a correlation structure among groups then the results are
provided in Table S8. We notice that the results are consistent with those found in Section
4 i.e. the group-corr method continues to be superior among the methods considered.
Web Appendix J Integrated Brier Score
One way to measure the prediction accuracy is to plot the observed Kaplan-Meier curve
along with the Kaplan-Meier curve based on samples from the posterior predictive model
(see Banerjee et al. 2003). We take a step further to calculate Brier score (BS) intro-











K̂(.) denotes the Kaplan-Meier estimate of the censoring distribution which is based on the
observations (ti, 1− δi), and Ŝ(.) stands for the estimated survival function. As the mathe-
matical form suggests, BS provides a numerical comparison between observed and estimated
survival functions. It has been shown useful to measure the goodness of t of a survival
model (Hothorn et al., 2006; Schumacher et al., 2007; Bonato et al., 2011). BS is dened
for each time point t, and hence can be added for the entire time range to obtain Integrated
Brier score, IBS = max(ti)
−1 ∫ max(ti)
0
BS(t)dt. We can see that, models with smaller scores
are preferred. Following Van Wieringen et al. (2009), we compute IBS using ipred package.
References
Analytics, R. and Weston, S. (2015a). doParallel: Foreach Parallel Adaptor for the 'parallel'
Package. R package version 1.0.10.
Analytics, R. and Weston, S. (2015b). foreach: Provides Foreach Looping Construct for R.
R package version 1.4.3.
9
Armagan, A., Dunson, D. B., Lee, J., Bajwa, W. U., and Strawn, N. (2013). Posterior
consistency in linear models under shrinkage priors. Biometrika, 100(4):10111018.
Banerjee, S., Wall, M. M., and Carlin, B. P. (2003). Frailty modeling for spatially correlated
survival data, with application to infant mortality in Minnesota. Biostatistics, 4(1):123
142.
Bates, D. and Maechler, M. (2016). Matrix: Sparse and Dense Matrix Classes and Methods.
R package version 1.2-7.1.
Bonato, V., Baladandayuthapani, V., Broom, B. M., Sulman, E. P., Aldape, K. D., and Do,
K.-A. (2011). Bayesian ensemble methods for survival prediction in gene expression data.
Bioinformatics, 27(3):359367.
Bradic, J., Fan, J., and Jiang, J. (2011). Regularization for Cox's proportional hazards
model with NP-dimensionality. Annals of Statistics, 39(6):3092.
Friedman, J., Hastie, T., and Tibshirani, R. (2010). Regularization paths for generalized
linear models via coordinate descent. Journal of Statistical Software, 33(1):1.
Gelfand, A. E., Hills, S. E., Racine-Poon, A., and Smith, A. F. (1990). Illustration of
Bayesian inference in normal data models using Gibbs sampling. Journal of the American
Statistical Association, 85(412):972985.
Genz, A. and Bretz, F. (2009). Computation of multivariate normal and t probabilities,
volume 195. Springer Science & Business Media.
Graf, E., Schmoor, C., Sauerbrei, W., and Schumacher, M. (1999). Assessment and compar-
ison of prognostic classication schemes for survival data. Statistics in Medicine, 18(17-
18):25292545.
Hothorn, T., Bühlmann, P., Dudoit, S., Molinaro, A., and Van Der Laan, M. J. (2006).
Survival ensembles. Biostatistics, 7(3):355373.
Hu, X. and Sun, S. (2015). RAD51 Gene 135G/C polymorphism and ovarian cancer risk: a
meta-analysis. International journal of clinical and experimental medicine, 8(12):22365.
Ibrahim, J. G., Chen, M.-H., and Gray, R. J. (2002). Bayesian models for gene expression
with DNA microarray data. Journal of the American Statistical Association, 97(457):88
99.
Ibrahim, J. G., Chen, M.-H., and Sinha, D. (2005). Bayesian Survival Analysis. Wiley
Online Library.
Jackson, C. H. (2011). Multi-State Models for Panel Data: The msm Package for R. Journal
of Statistical Software, 38(8):129.
Levanon, K., Sapoznik, S., Bahar-Shany, K., Brand, H., Shapira-Frommer, R., Korach, J.,
Hirsch, M. S., Roh, M. H., Miron, A., Liu, J. F., et al. (2014). FOXO3a loss is a frequent
early event in high-grade pelvic serous carcinogenesis. Oncogene, 33(35):4424.
10
Lose, F., Lovelock, P., Chenevix-Trench, G., Mann, G. J., Pupo, G. M., and Spurdle, A. B.
(2006). Variation in the RAD51 gene and familial breast cancer. Breast Cancer Research,
8(3):R26.
Myatt, S. S., Wang, J., Monteiro, L. J., Christian, M., Ho, K.-K., Fusi, L., Dina, R. E.,
Brosens, J. J., Ghaem-Maghami, S., and Lam, E. W.-F. (2010). Repression of FOXO1
expression by microRNAs in endometrial cancer. Cancer research, 70(1):367.
Neal, R. M. (2003). Slice sampling. Annals of Statistics, pages 705741.
Peters, A. and Hothorn, T. (2017). ipred: Improved Predictors. R package version 0.9-6.
Polson, N. G., Scott, J. G., and Windle, J. (2014). The Bayesian bridge. Journal of the
Royal Statistical Society: Series B (Statistical Methodology), 76(4):713733.
R Core Team (2016). R: A Language and Environment for Statistical Computing. R Foun-
dation for Statistical Computing, Vienna, Austria.
Robin, X., Turck, N., Hainard, A., Tiberti, N., Lisacek, F., Sanchez, J.-C., and Müller, M.
(2011). pROC: an open-source package for R and S+ to analyze and compare ROC curves.
BMC Bioinformatics, 12:77.
Schumacher, M., Binder, H., and Gerds, T. (2007). Assessment of survival prediction models
based on microarray data. Bioinformatics, 23(14):17681774.
Taylor, S., Lam, M., Pararasa, C., Brown, J. E., Carmichael, A. R., and Griths, H. R.
(2015). Evaluating the evidence for targeting FOXO3a in breast cancer: a systematic
review. Cancer cell international, 15(1):1.
Thacker, J. (2005). The RAD51 gene family, genetic instability and cancer. Cancer letters,
219(2):125135.
Van Wieringen, W. N., Kun, D., Hampel, R., and Boulesteix, A.-L. (2009). Survival pre-
diction using gene expression data: a review and comparison. Computational Statistics &
Data Analysis, 53(5):15901603.
Wickham, H. (2009). ggplot2: Elegant Graphics for Data Analysis. Springer-Verlag New
York.
Wu, Y. and Ghosal, S. (2008). Posterior consistency for some semi-parametric problems.




















































































0 2500 5000 7500 10000
iteration
Figure S2: Trace plots of posterior correlations. The top panel shows the trace plots of
correlations between KIRC and KIRP, KICH and KIRC, and KICH and KIRP kidney tu-
mor groups respectively for X1433EPSILON protein. Similarly, the second, third, and the
fourth panels plots correlations for X4EBP1, FOXO3A_pS318S321, and DIRAS3 proteins
respectively.
12
Figure S3: The upper panel plot is the posterior estimates of protein eects for dierent
tumor groups when regressions are run for each group separately in Kidney cancer data.

























































Figure S5: The upper panel plot is the posterior estimates of protein eects for dierent
female tumor groups when regressions are run for each group separately for female body
tumors. The lower panel plot is same for our proposed group-corr method.
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